Professor Myriam Arevalo-Herrera

PhD, B.Sc

Nationality: Colombian


Present positions

  • Professor, School of Health, Department of Clinical Laboratory, Universidad del Valle, Cali
  • Scientific Director, Malaria Vaccine and Drug Development Center - MVDC, Cali, Colombia

Areas of professional activity

  • Malaria Vaccine and Drug Development and Regional Coordination of the GLP-Network for Latin America (GLP/ALTO TDR program)

Key publications

  • Arévalo-Herrera M, Chitnis C, Herrera S. Current status of Plasmodium vivax vaccine. Human Vaccines. ;6(1). [Epub ahead of print]. [PubMed 20009526]
  • Herrera S, Fernández O, Manzano MR, Murrain B, Vergara J, Blanco P, Palacios R, Vélez JD, Epstein JE, Chen-Mok M, Reed ZH, Arévalo-Herrera M. Successful sporozoite challenge model in human volunteers with Plasmodium vivax strain derived from human donors. The American journal of tropical medicine and hygiene. 2009 Nov;81(5):740-6. [PubMed 19861603]
  • Brown GV, Moorthy VS, Reed Z, Mendis K, Arévalo-Herrera M, Alonso P; WHO MALVAC committee. Priorities in research and development of vaccines against Plasmodium vivax malaria. Vaccine. 2009 Dec 9;27(52):7228-35. Epub 2009 Sep 15. [PubMed 19761835]
  • Herrera S, Bonelo A, Perlaza BL, Fernández OL, Victoria L, Lenis AM, Soto L, Hurtado H, Acuña LM, Vélez JD, Palacios R, Chen-Mok M, Corradin G, Arévalo-Herrera M. Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine. The American journal of tropical medicine and hygiene. 2005 Nov;73(5 Suppl):3-9. [PubMed 16291760]
  • Perlaza BL, Valencia AZ, Zapata C, Castellanos A, Sauzet JP, Blanc C, Cohen J, Arévalo-Herrera M, Corradin G, Herrera S, Druilhe P. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides. European journal of immunology. 2008 Sep;38(9):2610-5. [PubMed 18792413]
Share